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Abstract
Introduction: Our purpose was to investigate variation within the IL-32 promoter and gene, and susceptibility to
and outcomes from infection associated acute lung injury (ALI).
Methods: Retrospective case-control study involving healthy individuals (controls) and patients (cases) with
infection-associated ALI. Two hundred fifty-eight healthy normal controls and 251 patients with infection-associated
ALI were used for comparison. The IL-32 promoter/gene was sequenced in 52 healthy Caucasian individuals to
identify single nucleotide polymorphisms (SNPs). Allelic discrimination was performed on 11 SNPs to determine
differences between cases and controls and outcomes in patients with infection associated ALI.
Results: Logistic and normal regression models were used to evaluate the associations with SNPs in cases and
controls, and outcomes in patients with infection associated ALI. rs12934561, an intronic SNP, was found to be
associated with risk for ALI in the case-control study and with more severe clinical course, as shown by increased
time on the ventilator and the presence of fluid unresponsive hypotension. Further, it was found that rs12934561
has gender-specific effects and strongly interacts with other SNPs.
Conclusions: A common IL-32 genotype, rs12934561, is associated with the risk of ALI as well as the need for
prolonged mechanical ventilatory support. This finding suggests that IL-32 is not only involved in the initiating
inflammatory and cellular events that result in ALI, but also participates in determining the severity of pulmonary
dysfunction associated with ALI.
Introduction
A c u t el u n gi n j u r y( A L I )a n di t sm o r es e v e r ef o r m ,t h e
acute respiratory distress syndrome (ARDS), are fre-
quently associated with sepsis [1,2]. Major cellular popu-
lations involved in these processes include alveolar and
tissue-based macrophages, epithelial and endothelial
cells, and activated neutrophils that migrate from the
circulation into the interstitial and alveolar spaces,
where they release reactive oxygen species and proin-
flammatory cytokines and chemokines, including TNF-
a,I L - 1 b, and IL-8 [3-8]. The acute inflammatory pro-
cess associated with ALI disrupts epithelial and endothe-
lial integrity, resulting in interstitial edema, leakage of
protein into the alveolar space, and tissue injury [9].
IL-32 has been proposed to play an important role in
modulating innate and adaptive responses to infection.
In initial studies, IL-32 was shown to induce the expres-
sion of TNF-a and IL-8 via the activation of p38 and
nuclear factor-kappa B (NF-B) [10]. IL-32 has also
been shown to associate with nucleotide oligomerization
domain (NOD) 1 and NOD2 ligands, facilitating the
release of IL-1b and IL-6 in a manner independent of
Toll-like receptor (TLR) activation [11]. IL-32 has been
reported to be constitutively expressed in human umbi-
lical vein endothelial cells and pulmonary vascular
endothelial cells, suggesting a role for IL-32 in endothe-
lial inflammation and endothelial initiated events,
including intravascular coagulation [12]. Increased levels
of IL-32 are present in the lungs of patients with
chronic obstructive pulmonary disease and correlate
with airflow decreases that are associated with this con-
dition [13]. Additionally, IL-32 has been linked to other
inflammatory diseases, including psoriasis [14,15],
Crohn disease [16], and rheumatoid arthritis [14-19].
The IL-32 gene is located on chromosome 16 p13.3
and comprises four splice variants: IL-32 a, b, δ,a n dg
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that, although all four isoforms are biologically active,
IL-32g was the most potent at inducing the production
of the cytokines in peripheral blood mononuclear cells
and macrophages. Polymorphisms have been described
in the IL-32 gene by the National Center for Biotechnol-
ogy Information; however, association studies between
IL-32 polymorphisms and disease have not been
reported. Therefore, given the involvement of IL-32 in
inflammation and its association with diseases associated
with dysregulated inflammatory responses, we hypothe-
sized that single-nucleotide polymorphisms (SNPs)
within the IL-32 gene or promoter (or both) would be
associated with susceptibility to or outcomes in patients
with infection-associated ALI.
Materials and methods
Case control
Volunteer selection
Healthy Caucasian volunteers, 19 to 89 years of age,
were recruited to determine polymorphisms in the IL-32
gene. The volunteer population consisted of 115 males
(with a mean age of 32.0 ± 8.9 years) and 143 females
(with a mean age of 37.0 ± 11.6 years). Each volunteer
signed an informed consent document. The study was
approved by the University of Colorado institutional
review board.
Patients with acute lung injury
All patients included in this study had been enrolled in
National Institutes of Health (NIH) ARDS Network stu-
dies and had received low tidal volume ventilation in
accordance with previously published protocols and ful-
filled all NIH ARDS Network protocol inclusion and
exclusion criteria [21]. All patients were Caucasian and
had infection-associated ALI as characterized by either
systemic or localized pulmonary infection as the investi-
gator-identified primary etiology for ALI. ALI was
defined by standard criteria [21]. Septic shock was
defined as a systolic blood pressure of less than 90 mm
Hg for at least 30 minutes despite fluid replacement or
the use of inotropic support to maintain blood pressure.
This genetic analysis study was approved by the Univer-
sity of Colorado Health Sciences Center and the Univer-
sity of Alabama at Birmingham institutional review
boards. Consent was obtained from all patients or their
surrogates before enrollment as part of their enrollment
into the NIH protocols.
Statistical analysis
Multiple-SNP logistic and linear models We used two
logistic and linear regression models to analyze our data.
The first model (the main-effect model) simultaneously
fitted age and sex, and all 22 main effects (that is, both
additive and dominant effects) of the 11 SNPs. The
second model (the interacting model) simultaneously
fitted age, sex, 22 main effects, 22 SNP-sex interactions,
and 220 epistatic interactions.
We standardized the continuous covariate, age, to
have a mean of 0 and a standard deviation of 0.5, and
coded sex as 0/1 binary variables, indicating males/
females, respectively. For each SNP, we denoted com-
mon homozygote (that is, the homozygote with higher
frequency), heterozygote, and rare homozygote by c, h,
and r, respectively. We coded the main-effect predictors
by using the Cockerham genetic model. The Cockerham
model defines two main effects for each SNP (that is,
additive and dominance effects, denoted by the suffixes
‘a’ and ‘d’ at the end of the SNP rs numbers). The addi-
tive predictor is coded as -1, 0, and 1 for c, h, and r,
and the dominance predictor as -0.5 for c and r and 0.5
for h, respectively [22,23]. The additive effect ‘a’ repre-
sents the genotypic effect (r - c)/2, and the dominance
effect ‘d’ measures h - (c + r)/2. A positive additive
effect (for example, odds ratio (OR) >1) indicates that
the rare homozygote increases risk compared with the
common homozygote, and a positive dominance effect
means that the heterozygote increases risk compared
with the mean of two homozygotes. The SNP-sex and
epistatic predictors were constructed by multiplying two
corresponding main-effect variables, introducing two
SNP-sex interactions for each SNP (that is, sex-additive
and sex-dominance interactions) and four epistatic
interactions for a pair of SNPs (that is, additive-additive,
additive-dominance, dominance-additive, and domi-
nance-dominance interactions).
Multiple-SNP analysis relieves the problem of multiple
testing encountered in single-SNP analysis, can accom-
modate linkage disequilibrium (LD) among the SNPs,
and has the advantage of providing potentially increased
power and reduced false-positives to detect causal var-
iants, better separating highly correlated predictors, and
more efficiently detecting epistatic interactions [24-26].
However, traditional regression procedures are usually
problematic, owing to potentially large numbers of cor-
related and complex variables. We addressed such issues
by using a Bayesian approach that places appropriate
prior distributions on coefficients to obtain stable esti-
mates. Specifically, we used Student-t prior distributions,
i.e.,βj|τ2
j ∼ N(0,τ2
j )andτ2
j ∼ Inv−χ2(νj,s2
j ),w i t ht h e
hyperparameters (vj,sj) reasonably preset, where bj is the
j
th coefficient in the model [25,26]. For covariates and
main effects of SNPs, we used the weakly informative
priors by setting (vj,sj) to be (1, 2.5) [27]. For sex-gene
and epistatic interactions, we chose (1, 2.5 Kmain/KGE)
and (1, 2.5Kmain/KGG), respectively, where Kmain,K GE,
and KGG are the total numbers of main, SNP-sex, and
epistatic effects in the model [26]. We used the
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with the Student t priors by estimating the marginal
posterior modes of the coefficients [25,26].
We used two summary measures, the deviance and
the Akaike information criterion (AIC), to compare dif-
ferent models. Lower deviance and AIC mean better fit
to data. On the basis of the fitted multiple-SNP logistic
models, we calculated the average predictive probability
for each genotype of each SNP averaging over all the
data points in the dataset and all other variables. We
performed similar calculations for each pair of SNPs
that showed significant epistatic interactions. We also
calculated the gender-specific average predictive prob-
abilities for SNPs that showed significant sex-specific
effects. The average predictive probabilities show which
genotypes increase or are protective against the risk and
how a genotype depends on the genotypes of another
SNP or covariate.
Haplotype analysis We performed haplotype analysis
on the data as a secondary approach complementary to
the above analysis. We employed the haplotype-sharing
approach, which is implemented in the software CHASe
[28]. Because CHASe handles genotype data only, age
and sex were not included in the haplotype analysis.
Results
Sequencing of the IL-32 gene
Sequencing the IL-32 gene and promoter identified a
total of 23 SNPs with allele frequencies ranging from 6%
to 48% (Additional file 1, Table S1). Nine SNPs were in
the promoter and 14 were located within the gene. One
SNP in the promoter (-954) and one in the intron (613)
had not been previously described. Rs4786370,
rs55699988, and rs28372698 (r
2 = 0.87) as well as
rs56037566 and rs11861531 (r
2 = 0.84) were tag SNPs.
Analysis of pairwise LD was relatively weak for the IL-
32 promoter and gene within this population (Addi-
tional file 1, Figure S1).
Characteristics of the ARDS Network population
Two hundred fifty-one Caucasian patients who had
infection-induced ALI and who were enrolled from NIH
ARDS Network trials were available for analysis. As
shown in Table 1, the average age of patients was 51.3 ±
15.6 years, and men and women were equally repre-
sented. Overall mortality for this population was 25%.
The primary source of infection was the lung, and pul-
monary infections were present in 55% of the patients.
An additional 258 healthy Caucasians were used to
determine associations between cases and controls.
Case-control study
Prior to the determination of whether IL-32 SNPs were
associated with risk for ALI, Hardy-Weinberg equilibrium
(HWE) was evaluated on cases and controls. SNPs
rs11860424 and rs9927163 showed some departure from
HWE (P < 0.05). Next, we compared 11 out of the 23
SNPs (which captured 14 out of the 23 SNPs using tag
SNPs) between healthy controls and patients with infec-
tion-associated ALI. We attempted to analyze the other
SNPs identified by sequencing; however, TaqMan assays
for these SNPs failed. Figure 1 displays the coefficient esti-
mates, standard errors, P values, and ORs for all of the
effects under the main-effect and interacting models for
the case-control study. The main-effect model detected
rs9927163 with a marginally significant dominance effect,
which was also present in the interacting model. The
interaction analysis identified two sex-specific effects,
rs11861531a.sex and rs12934561a.sex, and two epistatic
interactions, rs12934561d.rs1554999a and rs11641468a.
rs12934561a. The association of rs12934561 with risk for
ALI, which was not significant under the main-effect
model, became significant under the interacting model.
The interacting model had lower deviance and AIC than
the main-effect model, indicating that inclusion of sex-spe-
cific effects and epistatic interactions improved the fit of
the model to data.
For rs9927163, the heterozygote increased the risk of
developing ALI whereas homozygotes decreased the risk
(Additional file 1, Figure S2). The genotypic effects of
rs11861531 and rs12934561 depended on gender, with
males demonstrating relatively greater protection from
ALI than females, and the genotypic effects of the inter-
acting SNP varied with the genotypes of the second
SNP.
Table 1 Characteristics of acute lung injury in the ARDS
Network patient population
Number 251
Age in years
Mean ± SD 51.3 ± 15.6
Range 17 to 90
Male 50.0%
APACHE III, mean ± SD 96.2 ± 29.7
Mechanical ventilation 100%
Mortality
Overall 25.0%
Male 26.0%
Female 24.0%
Source of infection
Lung 55.0%
Peritoneum 4.0%
Vascular line 4.0%
Skin 2.0%
GI/Biliary tract 2.0%
Other 33.0%
APACHE III, Acute Physiology and Chronic Health Evaluation III; ARDS, acute
respiratory distress syndrome; GI, gastrointestinal; SD, standard deviation.
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acute lung injury
Figure 2 displays the coefficient estimates, standard
errors, P values, and ORs for the main-effect model and
the interacting model for death at 60 days (that is, death
or not by day 60) after study inclusion. The main-effect
model detected no SNP that was significantly associated
with death at day 60. However, the interaction analysis
found that rs2239301d and rs1555001a were associated
with an increased risk of death in patients with infec-
tion-associated ALI. There were also a sex-specific
effect, rs1555001a.sex, and one epistatic interaction,
rs11861531a.rs1293461a, that were both associated with
diminished risk for death at day 60. The interacting
model had lower deviance and AIC than the main-effect
model, indicating that inclusion of sex-specific effects
and epistatic interactions improved the fit of the model
to data (Additional file 1, Figure S3). The gene-sex
interaction of rs1555001 occurred mainly for the rare
homozygote, with increased risk of death among women
with this SNP, and the gene-gene interaction of
rs11861531 and rs1293461 occurred mainly for the
common homozygote of rs11861531 and rare homozy-
gote of rs1293461 (Additional file 1, Figure S3).
IL-32 SNPs and time on the ventilator and presence of
shock among patients with acute lung injury
To investigate a possible association between severity of
lung injury and SNPs, we analyzed the number of venti-
lator-free days (VFDs) associated with each IL-32 SNP
for patients with infection-associated ALI. Figure 3 dis-
plays the coefficient estimates, standard errors, and P
values for the main-effect model and the interacting
model for VFDs, an indicator of need for mechanical
ventilation. The main-effect model detected three SNPs
- rs11860424, rs11861531, and rs12934561 - significantly
associated with VFDs through additive effects. The
interacting model identified not only these three additive
effects but also an additional epistatic effect, rs1555001d.
rs4786370d, that was associated with reduced VFDs.
The interacting model reduced deviance and AIC and
thus improved the model fit to the data. In a second
Figure 1 Case-control study of the association of IL-32 SNPs with risk for developing infection-associated acute lung injury.T h el e f t
panel represents the analysis of simultaneously fitting age, sex, and main effects for all 11 identified IL-32 SNPs. The right panel represents the
analysis of simultaneously fitting age, sex, and main effects of all SNP, sex-gene, and epistatic interactions. The notation for main effects, a and d,
indicates additive and dominance effects, respectively. The term X1.X2 represents interaction between X1 and X2. Interactions with a P value of
greater than 0.05 are not displayed. The points and short lines represent estimates of effect and ± 2 standard errors, respectively. The numbers
at the right side are the P values (p), odds ratios (ORs), and 95% confidence intervals. The deviance (Dev) and Akaike information criterion (AIC)
under each model are also shown. IL, interleukin; SNP, single-nucleotide polymorphism.
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IL-32 SNPs and days on the ventilator (DOVs), another
indicator of the need for mechanical ventilation in criti-
cally ill patients with respiratory failure. The main-effect
model detected two SNPs, rs11861531a and
rs11641468a, that were significantly associated with
DOVs. rs11861531a was associated with a reduction in
the duration of requirement for mechanical ventilation,
whereas the time on mechanical ventilation was signifi-
cantly greater among patients with rs11641468. Under
the interacting model, the effect for rs11861531a, but
not that for rs11641468a, was still significant. The inter-
action analysis identified an additional SNP,
rs12934561a, that was associated with an increased
number of DOVs and three epistatic interactions,
rs12934561a.rs9927163a, rs11641468d.rs2239301a, and
rs11641468d.rs1555001a.
We next examined whether particular IL-32 SNPs
were associated with hemodynamic shock as assessed by
the Brussels criteria requirement of vasopressor support
to maintain normotension or by a systolic blood pres-
sure of less than 90 mm Hg despite adequate fluid
administration. Figure 5 shows the coefficient estimates,
standard errors, and P values for all of the effects under
the main-effect model and the interacting model for
shock using the Brussels score values. The main-effect
model detected one SNP, rs12934561a, significantly
associated with shock. The interacting model identified
not only this main effect but also one epistatic interac-
tion, rs1555001a.rs9927163a. This interaction reduced
deviance and AIC and thus improved the model fit to
the data. For rs1293461, the common homozygote was
associated with decreased risk of developing shock in
patients with infection-associated ALI, and the effects of
rs1555001 varied with the genotypes of rs9927163
(Additional file 1, Figure S4).
The main-effect model detected three SNPs -
rs11641468d, rs2239303d, and rs12934561d - that were
Figure 2 Association between IL-32 SNPs and 60-day mortality in patients with infection-associated acute lung injury. The left panel
represents the analysis of simultaneously fitting age, sex, and main effects of all the SNPs. The right panel represents the analysis of
simultaneously fitting age, sex, and main effects of all the SNP, sex-gene, and epistatic interactions. The notation for main effects, a and d,
indicates additive and dominance effects, respectively. The term X1.X2 represents interaction between X1 and X2. Interactions with a P value of
greater than 0.05 are not displayed. The points and short lines represent estimates of effects and ± 2 standard errors, respectively. The numbers
at the right side are the P values (p), odds ratios (ORs), and 95% confidence intervals. The deviance (Dev) and Akaike information criterion (AIC)
under each model are shown. IL, interleukin; SNP, single-nucleotide polymorphism.
Arcaroli et al. Critical Care 2011, 15:R138
http://ccforum.com/content/15/3/R138
Page 5 of 10significantly associated with shock, as defined by
sequential measurements of vital signs (Additional file 1,
Figure S5). The interacting model identified not only
the same three SNPs but also one epistatic interaction
(that is, rs11641468a.rs2239301a) (Additional file 1, Fig-
ure S6). The genotypic effects of rs11641468 varied with
the genotypes of rs2239301 (Additional file 1, Figure
S6).
Haplotype analysis
Because the haplotype method handles genotype data
only, the results are unadjusted for any covariates. Table
S2 of Additional file 1 shows the haplotypes and their
corresponding frequencies. The smallest P values from
analyzing each of the aforementioned phenotypes are all
within the region 1474 to 4153 (consisting of SNPs
rs9927163, rs2239301, rs11861531, rs11641468,
rs1555001, rs2239303, and rs12934561). After Bonfer-
roni correction, only the case-control and shock (as
defined by Brussels score criteria) phenotypes showed
significant signals. For the case-control phenotype, the
smallest P value is for the region 1544 to 2642 (consist-
ing of SNPs rs2239301, rs11861531, rs11641468, and
rs1555001; P value = 0.036 after Bonferroni correction).
However, several regions between 1474 and 4153 have
significant P values even after Bonferroni correction. For
shock defined by Brussels score criteria, the smallest P
value is in the region 3225 to 4153 (consisting of SNPs
rs2239303 and rs12934561; P value = 0.008 after Bonfer-
roni correction). The region 2642 to 4153 (consisting of
SNPs rs1555001, rs2239303, and rs12934561) is signifi-
cant as well (P value = 0.029 after Bonferroni
correction).
Discussion
IL-32 is a recently described cytokine that demonstrates
increased expression after engagement of TLRs and IL-1
receptors in endothelial, epithelial, monocytic, and other
Figure 3 Association between IL-32 SNPs and ventilator-free days. The left panel represents the analysis of simultaneously fitting age, sex,
and main effects of all the SNPs. The right panel represents the analysis of simultaneously fitting age, sex, and main effects for all the SNP, sex-
gene, and epistatic interactions. The notation for main effects, a and d, indicates additive and dominance effects, respectively. The term X1.X2
represents interaction between X1 and X2. Interactions with a P value of greater than 0.05 are not displayed. The points and short lines represent
estimates of effects and ± 2 standard errors, respectively. The numbers at the right side are the P values (p). The deviance (Dev) and Akaike
information criterion (AIC) under each model are shown. IL, interleukin; SNP, single-nucleotide polymorphism.
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proinflammatory cytokines, including TNF-a and IL-1b,
through intracellular pathways involving NF-B and the
p38 MAP kinase [16,29-31]. IL-32 appears to play an
important role in pathophysiologic states associated with
dysregulated inflammatory responses, including rheuma-
toid arthritis, chronic obstructive pulmonary disease,
psoriasis, and inflammatory bowel disease [13,18,32]. In
a mouse model of sepsis, IL-32 was shown to potentiate
peritonitis-induced elevations in serum levels of TNF-a
and IL-1b, and overexpression of the IL-32b isoform led
to reduced time to death [33].
ALI is accompanied by an intense inflammatory
response in the lungs, driven by the proinflammatory
cytokine and chemokine generation that initiates and
accompanies the accumulation of large numbers of acti-
vated neutrophils in the pulmonary interstitium and air-
ways [34]. ALI is also characterized by endothelial
alterations that are associated with microvascular
abnormalities and epithelial dysfunction that leads to
the leakage of proteins into the alveolar space, resulting
in diminished lung compliance and hypoxemia [35,36].
While there is limited information linking IL-32 to ALI,
involvement of this cytokine in the inflammatory reac-
tion that characterizes ALI, as suggested by the present
data, is not surprising, especially given that sepsis asso-
ciated with pulmonary or extra-pulmonary infections is
the most common etiologic factor for ALI [35,36]. How-
ever, previous studies have not specifically examined
either the role of IL-32 in ALI or the possibility that
genetically determined alterations in IL-32 might be
associated with risk for or outcome from ALI.
In the present studies, we characterized 23 SNPs in
the IL-32 promoter and gene. One SNP (-954) in the
promoter and an intronic SNP (613) had not previously
been described. When the IL-32 genotypes were exam-
ined in a case-control study, two intronic SNPs were
associated with enhanced risk for developing ALI. In
particular, heterozygosity of rs9927163 was associated
with an increased likelihood for the development of
Figure 4 Association between IL-32 SNPs and days on ventilator. The left panel represents the analysis of simultaneously fitting age, sex,
and main effects of all the SNPs. The right panel represents the analysis of simultaneously fitting age, sex, and main effects of all the SNP, sex-
gene, and epistatic interactions. The notation for main effects, a and d, indicates additive and dominance effects, respectively. The term X1.X2
represents interaction between X1 and X2. Interactions with a P value of greater than 0.05 are not displayed. The points and short lines represent
estimates of effects and ± 2 standard errors, respectively. The numbers at the right side are the P values (p). The deviance (Dev) and Akaike
information criterion (AIC) under each model are shown. IL, interleukin; SNP, single-nucleotide polymorphism.
Arcaroli et al. Critical Care 2011, 15:R138
http://ccforum.com/content/15/3/R138
Page 7 of 10ALI, whereas rs12934561 was associated with risk for
ALI mainly through sex-specific effects and epistatic
interactions, and a diminished effect was found primar-
ily in men. Both of these genotypes are fairly common
in Caucasian individuals; the allele frequency for
rs22967163 is approximately 25% and that for
rs12934561 is about 41%. While the functional signifi-
cance of these genotypes in terms of IL-32 expression is
unknown at present, these findings indicate that IL-32
genotypes are associated with risk for development of
ALI and suggest that IL-32 occupies an important role
in the pathogenesis of ALI.
Several IL-32 SNPs were significantly associated with
clinical outcome among patients with ALI. In particular,
rs12934561, an intronic SNP that was found to be asso-
ciated with risk for ALI in the case-control study, also
demonstrated an association with a more severe clinical
course, as defined by a longer period on the ventilator,
using both VFDs and time on ventilator as measures of
the need for mechanical ventilation. rs12934561 was
also associated with a higher prevalence of fluid unre-
sponsive hypotension. Although effects of other SNPs,
including rs223930d, rs1555001a, rs11641468d, and
rs2239303d, were associated with worse clinical outcome
(such as increased mortality at day 60, prolonged
requirement for mechanical ventilation, or the presence
of shock), none of these genotypes was present for mul-
tiple clinical parameters, as was the case of rs12934561.
The present results indicate that IL-32 genotypes are
associated not only with risk for the development of
ALI but also with outcome from this critical illness.
Such associations between IL-32 SNPs and ALI are not
surprising given the multiple cellular populations that
express this cytokine and that participate in the patho-
genesis of ALI, including macrophages, endothelial, and
epithelial cells, as well as the ability of IL-32 to affect
inflammatory and other pathways known to mediate
pulmonary and extra-pulmonary organ dysfunction
Figure 5 Association between IL-32 SNPs and shock, using the Brussels score criteria for vasopressor requiring hypotension.T h el e f t
panel represents the analysis of simultaneously fitting age, sex, and main effects of all the SNPs. The right panel represents the analysis of
simultaneously fitting age, sex, and main effects of all the SNP, sex-gene, and epistatic interactions. The notation for main effects, a and d,
indicates additive and dominance effects, respectively. The term X1.X2 represents interaction between X1 and X2. Interactions with a P value of
greater than 0.05 are not displayed. The points and short lines represent estimates of effects and ± 2 standard errors, respectively. The numbers
at the right side are the P values (p), odds ratios (OR), and 95% confidence intervals. The deviance (Dev) and Akaike information criterion (AIC)
under each model are shown. IL, interleukin; SNP, single-nucleotide polymorphism.
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enhanced after engagement of TLR4 receptors by
ligands, including LPS, that play a major initiating role
in ALI due to sepsis, hemorrhage, trauma, or hyperoxia
[11,12,32,33]. IL-1b and TNF-a, two cytokines whose
expression is induced by IL-32, have been shown to be
present in high concentrations in the lungs during ALI
and to participate in potentiating neutrophil recruitment
and producing pulmonary injury in this setting [8,37,38].
Of note, IL-1b, which is found in high concentrations in
the alveolar space and airways during ALI, induces IL-
32 expression and thereby may participate in potentiat-
ing inflammatory cascades, resulting in upregulation of
its own levels as well as those for IL-32 [12,32,33]. IL-32
has been shown to upregulate the C-X-C chemokine IL-
8 [12], which is known to be expressed at high levels in
the lungs during ALI and has potent ability to enhance
recruitment of neutrophils, a cell population that plays a
major role in mediating pulmonary injury during ALI,
into the pulmonary parenchyma and airways [39-41].
Although IL-32 SNP rs12934561 was shown to be
associated with risk for and worse outcomes from ALI,
there are several limitations with this study. Only 11 out
of the 23 SNPs were genotyped (12 failed assay design),
and LD between rs12934561 and one or more of these
SNPs could possibly exist. Therefore, the potential SNP
associated with outcome from ALI may not be
rs12934561. In addition, the sample size in this study is
not robust. Therefore, it is possible that the association
between ALI and other SNPs may be missed because of
limited statistical power. Although our analysis controls
type I error rate well, there is the possibility that
rs12934561 is a false-positive finding, and this finding
will require confirmation with a validation population,
preferably with larger sample size and denser markers.
Finally, functional studies of rs12934561 were not per-
formed; thus, further studies are warranted to have a
better understanding of the role of this IL-32 SNP in
altering IL-32 function and ultimately outcomes in ALI.
Conclusions
While the present studies do not establish the functional
significance of the IL-32 SNPs found to be associated with
risk for and outcome from ALI, they do support the
hypothesis that IL-32 plays an important role in the patho-
genesis of ALI. The fact that a common IL-32 genotype,
rs12934561, was associated with ALI and interacted with
other SNPs as well as the need for prolonged mechanical
ventilatory support in patients with this condition suggests
that IL-32 not only is involved in the initiating inflamma-
tory and cellular events that result in ALI but also partici-
pates in determining the severity of pulmonary
dysfunction associated with ALI. Although future preclini-
cal and clinical interventional studies will be necessary to
establish the involvement of IL-32 in ALI, the present
results are fully supportive of a major role for IL-32 in
determining both propensity for and severity of ALI.
Key messages
￿ IL-32 appears to play an important role in patho-
physiologic states associated with dysregulated
inflammatory responses.
￿ The IL-32 SNP rs12934561 is associated with an
increased risk of acute lung injury (ALI) as well as
the need for prolonged mechanical ventilatory
support.
￿ These results suggest that IL-32 not only is
involved in the initiating inflammatory and cellular
events that result in ALI but also participates in
determining the severity of pulmonary dysfunction
associated with ALI.
Additional material
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Results.
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